Prevention First

Vaccination at the Heart of Public Health. Vaccines Europe calls on EU policy-makers to develop a comprehensive vaccination strategy through five core policy asks.

Read more

Vaccine Market Access in the EU

How long for a vaccine to reach European Population? 6,4 years is the median time lag between marketing authorisation and effective population access

Find out more

Vaccines Europe at a glance

Vaccines Europe acts as the cohesive voice of the Europe-based vaccine industry sector and is a trusted partner for public authorities. Find out more about our association and contribution to Europe.

Start Prezi

The vaccine industry
in figures

With 47% growth in R&D investment over the past eight years and over 70% of current R&D projects based on new antigens and new combinations, Vaccines Europe members highly contribute to innovation.

Find out more

An industry for healthy lives

As the EU-wide recognised vaccine industry stakeholder, Vaccines Europe represents major innovative research-based vaccine companies operating in Europe and is currently expanding to SMEs.
Find out more about our services, the opportunites we offer and how to become a member.

Find out how to become a member

Latest News

RSS

Vaccines Europe is recruiting a Regulatory and Scientific Affairs Manager

2015 07 01 Written by Vaccines Europe

Highlights:

Job Description: 
The person appointed will be based in the Vaccines Europe/EFPIA Office in Brussels, Belgium and will report directly to the Vaccines Europe Executive Director. Read more…

Vaccines HTA panel session at HTAi Annual Conference 2015 in Oslo, 15-17June

2015 05 27 Written by Vaccines Europe

Vaccines Europe is pleased to announce its participation in occasion of the upcoming HTAi Annual Conference 2015 in Oslo next 15 to 17 June. On Wednesday 17 June morning, Vaccines Europe will be hosting a panel session entitled “Assessing the Value of Vaccines: What’s needed to make Evidence-based Health Policy Decisions?”. Featuring participation from key experts across academia, public bodies and industry, the session will aim to discuss how to expedite and streamline evaluation practices within and across countries with stakeholders involved in vaccines’ value assessment and decision-making.  Read more…

Vaccines Europe calls for a European Influenza Day

2015 04 30 Written by Vaccines Europe

Luxembourg, April 30th, 2015 – Vaccines Europe launches a call on the European Commission and Member States to align and streamline communications activities around the seasonal influenza vaccination campaigns by setting a European Influenza Day to launch seasonal vaccination every year.

Vaccines Europe President Andrea Rappagliosi prompts the establishment of a common EU-wide day to launch the seasonal influenza vaccination campaigns across all Member States in occasion of the DG SANTÉ High- Level Hearing on Seasonal Influenza Vaccination.

The meeting, organised by the European Commission back-to-back to the Workshop on joint procurement being held in Luxembourg on 29-30 April 2015, is bringing together key stakeholders across public health, regulatory, industry and civil society to discuss concrete measures that can increase flu vaccination rates in the EU. Read more…

See all News